Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Evaluation of STOP Protocol Implementation for Abnormal TCD in Children with Sickle Cell Anemia at Risk for Stroke: Displace Consortium

Shannon Phillips, PhDRN, Alyssa M Schlenz, PhD, Mary Dooley, MS, Martina Mueller, PhD, Logan P Sirline, MPH, Cathy L Melvin, PhD MPH, Robert J Adams, MD MS, Julie Kanter, MD

Blood (2020) 136 (Supplement 1): 22–23.

https://doi.org/10.1182/blood-2020-141970

Published: 2020

Journal Articles

Sickle Stroke Screen: A Patient-Centered Educational Initiative for Children with Sickle Cell Anemia in the Displace Consortium

Alyssa M Schlenz, PhD, Shannon Phillips, PhDRN, Martina Mueller, PhD, Cathy L Melvin, PhD MPH, Robert J Adams, MD MS, Julie Kanter, MD

Blood (2020) 136 (Supplement 1): 43–44.

https://doi.org/10.1182/blood-2020-141963

Published: 2020

Journal Articles

Hydroxyurea Therapy to Prevent Incident Stroke Among Children with Sickle Cell Anaemia in Jamaica: The Extend Trial

Angela Rankine-Mullings, MBBS, Marvin Ellsworth Reid, MB, BS, PhD, Deanne Soares, MBBS,DM Radiology, Carolyn Taylor-Bryan, MBBS, PhD BSc, DM, Margaret Wisdom-Phipps, RN, RM, Karen Aldred, MSc, Teresa Latham, MA, Jennifer Knight-Madden, MBBS, PhD, Lesley King, MBBS, MRCP, Asha Badaloo, PhD, Adam Lane, PhD, Robert J. Adams, MD MS, Russell E. Ware, MD PhD

Blood (2019) 134 (Supplement_1): 2269.

https://doi.org/10.1182/blood-2019-126781

Published: 2019

Journal Articles

Characteristics of Children with Abnormal TCD in the Modern Era: Results from the Displace Consortium

Julie Kanter, MD, Mary Dooley, MS, Logan P Sirline, MPH, Martina Mueller, PhD, Shannon Phillips, PhD RN, Alyssa M Schlenz, PhD, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS

Blood (2019) 134 (Supplement_1): 2270.

https://doi.org/10.1182/blood-2019-129951

Published: 2019

Journal Articles

Barriers and Facilitators to Transcranial Doppler Screening for Stroke Prevention in Children with Sickle Cell Anemia: Results from the Displace Consortium

Shannon Phillips, PhD RN, Alyssa M Schlenz, PhD, Martina Mueller, PhD, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS, Julie Kanter, MD

Blood (2019) 134 (Supplement_1): 3393.

https://doi.org/10.1182/blood-2019-128716

Published: 2019

Journal Articles

Barriers and Facilitators to Chronic Red Cell Transfusion Therapy for Children with Sickle Cell Anemia: Results from the Displace Consortium

Alyssa M Schlenz, PhD, Shannon Phillips, PhD RN, Martina Mueller, PhD, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS

Blood (2019) 134 (Supplement_1): 4697.

https://doi.org/10.1182/blood-2019-130646

Published: 2019

Journal Articles

Results from the Displace Consortium: Practice Patterns on the Use of Transcranial Doppler Screening for Risk of Stroke in Children with Sickle Cell Anemia

Shannon Phillips, PhD RN, Martina Mueller, PhD, Alyssa M Schlenz, PhD, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 4697.

https://doi.org/10.1182/blood-2018-99-116709

Published: 2018

Journal Articles

Practice Patterns in the Use of MRI/MRA and Chronic Transfusion Therapy for Monitoring and Treatment of Stroke in Pediatric Patients with Sickle Cell Anemia

Alyssa M Schlenz, PhD, Martina Mueller, PhD, Shannon Phillips, PhD RN, Cathy Melvin, PhD MPH, Robert J. Adams, MD MS, Julie Kanter, MD

Blood (2018) 132 (Supplement 1): 4716.

https://doi.org/10.1182/blood-2018-99-116968

Published: 2018

Journal Articles

Association of Sickle Cell Trait with Risk of Coronary Heart Disease in African Americans

Blood (2016) 128 (22): 11.

https://doi.org/10.1182/blood.V128.22.11.11

Published: 2016

Journal Articles

Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

Russell E. Ware, MD PhD, Adam Lane, PhD, William H Schultz, MHS PA, Hamayun Imran, MD, Margaret T. Lee, MD, Matthew M Heeney, MD, Clark Brown, MD PhD, Lori Luchtman-Jones, MD, Jennifer Webb, MD, Sherron Jackson, MD, Banu Aygun, MD, Scott T. Miller, MD, Jennifer A Rothman, MD, Alexis A. Thompson, MD MPH, Judy Luden, CCRP, Barry R Davis, MD PhD, Robert J. Adams, MD

Blood (2016) 128 (22): 1019.

https://doi.org/10.1182/blood.V128.22.1019.1019

Published: 2016

Journal Articles

Sickle Cell Disease Measures in the Phenx Toolkit

Kathryn L. Hassell, MD, James R. Eckman, MD, Elizabeth S Klings, MD, Robert J. Adams, MD MS, Julie A. Panepinto, MD MSPH, Tracey Grant, MS, Wayne Huggins, PhD, Deborah R. Maiese, MPA, Ellen M. Werner, PhD, Erin M. Ramos, PhD MPH, Carol M. Hamilton, PhD

Blood (2015) 126 (23): 281.

https://doi.org/10.1182/blood.V126.23.281.281

Published: 2015

Journal Articles

Impact of TCD Screening Protocol on the Incidence of Hemorrhagic Stroke in Children and Young Adults with Sickle Cell Disease

Julie Kanter, MD, Janet Kwiatkowski, MD, Heather J. Fullerton, MD, Jenifer Voeks, Ellen Debenham, RN, Lynette J Brown, Robert J. Adams, MD MS

Blood (2015) 126 (23): 3402.

https://doi.org/10.1182/blood.V126.23.3402.3402

Published: 2015

Journal Articles

Ischemic Stroke in Children and Young Adults with Sickle Cell Disease (SCD) in the Post-STOP Era

Janet L. Kwiatkowski, MD MSCE, Julie Kanter, MD, Heather J. Fullerton, MD, Jenifer Voeks, Ellen Debenham, RN, David G Brown, Lynette J Brown, Robert J. Adams, MD MS

Blood (2015) 126 (23): 68.

https://doi.org/10.1182/blood.V126.23.68.68

Published: 2015

Journal Articles

Barriers to Implementation of Evidence-Based Stroke Prevention in Sickle Cell Disease: A Preliminary Study

Alyssa M Schlenz, PhD, Joannie Hayes, MD, Martina Mueller, PhD, Shannon Hudson, PhD, R.N., Robert J. Adams, MD MS, Julie Kanter, MD

Blood (2015) 126 (23): 749.

https://doi.org/10.1182/blood.V126.23.749.749

Published: 2015

Journal Articles

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Russell E. Ware, MD PhD, Barry R Davis, MD PhD, William H Schultz, MHS PA, Clark Brown, MD PhD, Banu Aygun, MD, Sharada A. Sarnaik, MD, Isaac Odame, MD, Beng Fuh, MD, Alex George, MD, PhD, William Owen, MD, Lori Luchtman-Jones, MD, Zora R. Rogers, MD, Lee Hilliard, MD, Cynthia Gauger, MD, Connie M. Piccone, MD, Margaret T. Lee, MD, Janet Kwiatkowski, MD, Sherron Jackson, MD, Scott T. Miller, MD, Carla W Roberts, MD, Matthew M. Heeney, MD FRCP(C), Theodosia A. Kalfa, MD PhD, Stephen C Nelson, MD, Hamayun Imran, MD, Kerri A Nottage, MD MPH, Ofelia A. Alvarez, MD, Melissa Rhodes, MD, Alexis A. Thompson, MD, Jennifer Rothman, MD, Kathleen J. Helton, MD, Donna Roberts, MD, Jamie Coleman, MD, Melanie J Bonner, PhD, Abdullah Kutlar, MD, Niren Patel, MD, John C Wood, MD PhD, Linda Piller, MD, Peng Wei, PhD, Judy Luden, CCRP, Nicole A. Mortier, MHS, PA-C, Susan Stuber, MA, Naomi L.C. Luban, MD, Alan R. Cohen, MD, Sara L Pressel, MS, Robert J. Adams, MD MS

Blood (2015) 126 (23): 3.

https://doi.org/10.1182/blood.V126.23.3.3

Published: 2015

Journal Articles

Effects of Chronic Transfusion Therapy on transcranial Doppler Ultrasonography Velocities in Children with Sickle Cell Anemia at Risk for Primary Stroke: Baseline Findings from the Twitch Trial

Hamayun Imran, MD MSc, Banu Aygun, MD, Barry R. Davis, MD PhD, Sara L. Pressel, MS, William Herbert Schultz, PA-C, Sherron M. Jackson, MD, Sharon A. Singh, MD, Sharada A. Sarnaik, MD, Cynthia A. Gauger, MD, Beng Fuh, MD, Kathleen J. Helton, MD, Donna Roberts, MD, Robert J. Adams, MD MS, Russell E. Ware, MD, PhD

Blood (2014) 124 (21): 87.

https://doi.org/10.1182/blood.V124.21.87.87

Published: 2014

Journal Articles

Effects of Chronic Transfusion Therapy on MRI and MRA in Children with Sickle Cell Anemia at Risk for Primary Stroke: Baseline Imaging from the Twitch Trial

Kathleen J. Helton, MD, Donna Roberts, MD, William Herbert Schultz, PA-C, Barry R. Davis, MD PhD, Theodosia A. Kalfa, MD PhD, Sara L. Pressel, MS, Robert J. Adams, MD MS, Russell E. Ware, MD, PhD

Blood (2014) 124 (21): 4052.

https://doi.org/10.1182/blood.V124.21.4052.4052

Published: 2014

Journal Articles

Is Sickle Cell Trait Associated with Incident Cardiovascular Outcomes in African Americans?

Hyacinth Idu Hyacinth, MD MPH, Cara Carty, PhD, Gregory L. Burke, MD MS, Rakhi P. Naik, MD, Robert J. Adams, MD MS, Beatrice E. Gee, MD, Will Longstreth, MD MPH, Leonard Egede, MDMS, Daniel T. Lackland, DrPH, Charles S. Greenberg, MD, Kelly J. Hunt, PhD, Mark M. Kindy, PhD, Herman Taylor, MD, JoAnn E. Manson, MD, Mattthew Allison, MD MPH, Wilson G. James, MD MS, Alexander Reiner, MD

Blood (2014) 124 (21): 4920.

https://doi.org/10.1182/blood.V124.21.4920.4920

Published: 2014

Journal Articles

Transcranial Doppler Ultrasound (TCD) Outcomes for Children with Prior Normal TCD: Post-STOP Study Results

Janet L. Kwiatkowski, MD MSCE, Heather Fullerton, MD MAS, Jennifer Voeks, Lynette Brown, Ellen Debenham, RN, Robert J. Adams, MD MS

Blood (2014) 124 (21): 562.

https://doi.org/10.1182/blood.V124.21.562.562

Published: 2014

Journal Articles

Effect Of Blood Transfusion Therapy On Coagulation Activation In Sickle Cell Disease Patients With High TCD Velocity

Hyacinth Idu Hyacinth, MBBS, MPH, Robert J. Adams, MD, MS, Jacqueline Hibbert, PhD, Beatrice E Gee, MD

Blood (2013) 122 (21): 2225.

https://doi.org/10.1182/blood.V122.21.2225.2225

Published: 2013

NARROW

Evaluation of STOP Protocol Implementation for Abnormal TCD in Children with Sickle Cell Anemia at Risk for Stroke: Displace Consortium

Sickle Stroke Screen: A Patient-Centered Educational Initiative for Children with Sickle Cell Anemia in the Displace Consortium

Hydroxyurea Therapy to Prevent Incident Stroke Among Children with Sickle Cell Anaemia in Jamaica: The Extend Trial

Characteristics of Children with Abnormal TCD in the Modern Era: Results from the Displace Consortium

Barriers and Facilitators to Transcranial Doppler Screening for Stroke Prevention in Children with Sickle Cell Anemia: Results from the Displace Consortium

Barriers and Facilitators to Chronic Red Cell Transfusion Therapy for Children with Sickle Cell Anemia: Results from the Displace Consortium

Results from the Displace Consortium: Practice Patterns on the Use of Transcranial Doppler Screening for Risk of Stroke in Children with Sickle Cell Anemia

Practice Patterns in the Use of MRI/MRA and Chronic Transfusion Therapy for Monitoring and Treatment of Stroke in Pediatric Patients with Sickle Cell Anemia

Association of Sickle Cell Trait with Risk of Coronary Heart Disease in African Americans

Variation in Serial TCD Velocity Measurements in the TCD with Transfusions Changing to Hydroxyurea (TWiTCH) Trial

Sickle Cell Disease Measures in the Phenx Toolkit

Impact of TCD Screening Protocol on the Incidence of Hemorrhagic Stroke in Children and Young Adults with Sickle Cell Disease

Ischemic Stroke in Children and Young Adults with Sickle Cell Disease (SCD) in the Post-STOP Era

Barriers to Implementation of Evidence-Based Stroke Prevention in Sickle Cell Disease: A Preliminary Study

TCD with Transfusions Changing to Hydroxyurea (TWiTCH): Hydroxyurea Therapy As an Alternative to Transfusions for Primary Stroke Prevention in Children with Sickle Cell Anemia

Effects of Chronic Transfusion Therapy on transcranial Doppler Ultrasonography Velocities in Children with Sickle Cell Anemia at Risk for Primary Stroke: Baseline Findings from the Twitch Trial

Effects of Chronic Transfusion Therapy on MRI and MRA in Children with Sickle Cell Anemia at Risk for Primary Stroke: Baseline Imaging from the Twitch Trial

Is Sickle Cell Trait Associated with Incident Cardiovascular Outcomes in African Americans?

Transcranial Doppler Ultrasound (TCD) Outcomes for Children with Prior Normal TCD: Post-STOP Study Results

Effect Of Blood Transfusion Therapy On Coagulation Activation In Sickle Cell Disease Patients With High TCD Velocity

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only